KBC Group
IRON icon

KBC Group’s Disc Medicine IRON Stock Holding History

KBC Group’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$66K Hold
1,011
– – ﹤0.01% 1623
2026
Q2 		$74K Hold
1,011
– – ﹤0.01% 1568
2026
Q1 		$65K Hold
1,011
– – ﹤0.01% 1552
2025
Q4 		$80K Buy
+1,011
New +$85.4K ﹤0.01% 1427

Other funds holding IRON

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
iA Global Asset Management
iA Global Asset Management Quebec, Quebec, Canada $8.54B AUM 39.73% 1-Year Est. Return
Pinnacle Associates
Pinnacle Associates New York $8.92B AUM 43.91% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $69.5B AUM 31.38% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return
Pinnacle Wealth Planning Services
Pinnacle Wealth Planning Services Mansfield, Ohio $1.03B AUM 22.32% 1-Year Est. Return
Sterling Capital Management
Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return
GF Fund Management
GF Fund Management Guangzhou, China $7.72B AUM 122.96% 1-Year Est. Return

KBC Group's IRON Position: Q3 2026 in Review

KBC Group held its Disc Medicine (IRON) position steady in Q3 2026 at 1,011 shares worth $66K. The position accounts for ﹤0.01% of the portfolio, ranked #1623.

KBC Group first reported a position in IRON in Q4 2025 and has held it in 4 quarters since. The position peaked at $80K in Q4 2025. 33 funds tracked by Wall St. Rank hold IRON as of Q3 2026.

  • KBC Group held 1,011 shares of Disc Medicine worth $66K as of Q3 2026.
  • KBC Group left its Disc Medicine share count unchanged in Q3 2026.
  • Disc Medicine made up ﹤0.01% of KBC Group's portfolio in Q3 2026, its #1623 holding.
  • KBC Group first reported a position in Disc Medicine in Q4 2025 and has held it in 4 quarters since.
  • KBC Group's Disc Medicine position peaked at $80K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Disc Medicine as of Q3 2026.

Based on KBC Group's 13F filing for Q3 2026, filed 22 Oct 2026.